Publication:
Evaluation of signal transducer and activator of transcription 3 (STAT-3) protein expression in non-hodgkin lymphoma cases in Hospital Universiti Sains Malaysia

Loading...
Thumbnail Image
Date
2023
Authors
Muhamad, Izyan Rifhana
Journal Title
Journal ISSN
Volume Title
Publisher
Research Projects
Organizational Units
Journal Issue
Abstract
Background: Evolving targeted therapy on Janus Associated Kinase-Signal Transducer and Activator of Transcription (JAK-STAT) signalling pathway especially pertaining to STAT-3 protein in non-Hodgkin lymphoma (NHL), provide new treatment strategies. STAT-3 protein also related to prognostication of NHL. Hence, we aimed to evaluate the expression of STAT-3 protein in NHL cases, diagnosed in Hospital Universiti Sains Malaysia. Methods: A retrospective cross sectional study using formalin fixed paraffin embedded tissue blocks of 95 NHL cases were obtained. STAT-3 immunostaining was performed and evaluated. The association between clinicopathological characteristics and STAT-3 protein expression was analysed using the Pearson chi-square and Fisher’s exact test. A p-value of < 0.05 is considered statistically significant. Results: Majority of the cases (78.9 %) have positive STAT-3 protein expression. 64.2 % were among aggressive B cell NHL whilst 20 % of them are Diffuse Large B Cell Lymphoma, non-germinal centre B subtype (DLBCL-NGCB). There is significant association between STAT-3 protein expression with DLBCL subtypes (p = 0.046). Conclusion: STAT-3 protein was significantly associated with DLBCL, one of the aggressive B cell lymphoma subtypes. It could be one of the possible markers to prognosis in NHL. However, a more extensive study with a combination of JAK protein needs to be done in the future to elucidate the mechanism of the JAK-STAT pathway in NHL and its associated role.
Description
Keywords
Lymphoma , Non-hodgkin
Citation